KISS (Keep It Simple Stupid): Focus On Catalysts!
Dear Esteemed Investors,
Let me ask you this question:?Do you know why sometimes you make things so complicated that it hurt your investment profits?
The reason is that you're engaging in self-sabotaging activities.
Deep down, you don't believe that you deserve it.
As such, you'd find ways to mess up your investment success like forgetting your base or following silly advice.
You'd idolize guys who have no expert knowledge or understanding of drugs/medicines.
For example, the?Reata Pharmaceuticals?(RETA) play has extremely high chances of bringing you nearly two folds gains.?
And yet, you took a pass on it.
You let the news media talk you out of it.
You know that?Madrigal Pharmaceuticals?(MDGL) holds the holy grail toward capturing the NASH market.
And yet, you didn't Power Trade the MAESTRO-NASH data catalyst.?
Worst of all, you don't even have it in your long-term portfolio.
Same thing with ImmunoGen's recent Phase 3 (MIRASOL) data release.
We went over in our Open-Mic Webinar that ImmunoGen is our next play that has a GREAT chance of hitting BIG.
And yet, you ignored it.
I also told you not to overconcentrate in any one play.?
That way, you won't lock up your capital into one stock.
As such, you can have additional dry power to allocate to various Power Trading Catalysts positions.
In doing so, you can roll the ones not hitting immediately into your Long-term positions.?
TG Therapeutics?(TGTX) didn't pop right away but it delivered alphas in the months thereafter.
By diversifying into several plays, you'd enjoy taking profits as you capture the "popping stock."
Now, if you're wondering what's up with all these marketing blogs?
You know I don't bullshit you. I run my own small business.
If I don't do my marketing, no one is going to do it for me.
But the content in my market blogs can help you right your ship to the Land of mega profits.
If you got past that, I'll show you that conquering biotech profits is simple.
And, you should follow the KISS approach.
领英推荐
That is to say, Keep It Simple Approach.
First, you need to build two portfolios.
One is for your long-term growth biotech holding.?
Keep your turnaround very low in that one.
Flipping in and out (buying/selling too often) will reduce your long-term gains.
Don't chop a tree if you've only planted it for a year or two.
If you tell that o Warren Buffett, he'll agree with you.
Now, the second portfolio is for your Power Catalyst Trades to boost your gains.
Let's say if you missed out and lost at times, that's ok.
I missed my forecast when I doubted myself.
You remember TG's story?
I was wrong when I reversed my initial forecast the day before the FDA issued the decision.
After that lesson, I learned to filter out what market noises and even what the data is saying.
Instead, I've focused much more on my intuition.
Earlier today inside IBI, I just published another research that has an upcoming Power Catalyst trade.
If you lost some prior grounds, this one can help you regain it.
Again, remember to spread out your trades to several stocks with pending catalysts.
That way, when some flop you'd still enjoy an overall winning record.
See what our members are saying ... There's?much more here?since 2017.
As such, we're offering you our?no-obligation 2-week FREE trial?to begin your biotech winning process.
To your success,
Harvey Tran, MD
Analyst's Disclosure:?I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.
As a medical doctor/market expert, I'm not a registered investment advisor. Despite that I strive to provide the most accurate information, I neither guarantee the accuracy nor timeliness. Past performance does NOT guarantee future results. I reserve the right to make any investment decision for myself and my affiliates pertaining to any security without notification except where it is required by law. I'm also NOT responsible for the action of my affiliates. The thesis that I presented may change anytime due to the changing nature of information itself. Investing in stocks and options can result in a loss of capital. The information presented should NOT be construed as recommendations to buy or sell any form of security. My articles are best utilized as educational and informational materials to assist investors in your own due diligence process. That said, you are expected to perform your own due diligence and take responsibility for your action. You should also consult with your own financial advisor for specific guidance, as financial circumstances are individualized. That aside, I'm not giving you professional medical advice. Before embarking on any health-changing behavior, make sure you consult with your own doctor.
Seeking Alpha's Disclosure:?Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.